08:53 AM EDT, 06/05/2024 (MT Newswires) -- Health care stocks were steady premarket Wednesday with the Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) recently inactive.

Vir Biotechnology ( VIR ) was nearly12% higher after saying preliminary data from a mid-stage trial evaluating its investigational hepatitis therapies tobevibart and elebsiran showed sustained virologic response from the two drugs, suggesting potential efficacy.